Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Matzke

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Annals of Pharmacotherapy|February 18, 2011
Health Care Policy 2011: implications for pharmacistsGary R Matzke
The Annals of Pharmacotherapy|April 14, 2012
Health care reform 2011: opportunities for pharmacistsGary R Matzke
The Annals of Pharmacotherapy|November 19, 2009
Healthcare reform 2009 and its implications for pharmacistsGary R Matzke
The Annals of Pharmacotherapy|August 13, 2010
Health-care reform 2010: how will it impact you and your practice?Gary R Matzke, Leigh Ann Ross
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 10, 2017
Population health and medicine: Policy and financial driversJill E Lavigne, Jack Brown, Gary R Matzke
American Journal of Pharmaceutical Education|May 12, 2016
A Novel Education and Training Program to Enhance Student AdvocacyAlex J Adams, Gary R Matzke, Kenneth L McCall
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2003
Hepatic drug metabolism and transport in patients with kidney diseaseThomas D Nolin, Reginald F Frye, Gary R Matzke
Pharmacotherapy|April 29, 2009
Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysisBrett H Heintz, Gary R Matzke, William E Dager
Antimicrobial Agents and Chemotherapy|January 5, 2011
Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenemIolanda Cirillo, Nicole Vaccaro, Dainius Balis, et al.
Journal of Clinical Pharmacology|August 5, 2015
Influence of kidney disease on drug disposition: An assessment of industry studies submitted to the FDA for new chemical entities 1999-2010Gary R Matzke, Thomas C Dowling, Samantha A Marks, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|February 18, 2011
Health Care Policy 2011: implications for pharmacistsGary R Matzke
The Annals of Pharmacotherapy|April 14, 2012
Health care reform 2011: opportunities for pharmacistsGary R Matzke
The Annals of Pharmacotherapy|November 19, 2009
Healthcare reform 2009 and its implications for pharmacistsGary R Matzke
The Annals of Pharmacotherapy|August 13, 2010
Health-care reform 2010: how will it impact you and your practice?Gary R Matzke, Leigh Ann Ross
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 10, 2017
Population health and medicine: Policy and financial driversJill E Lavigne, Jack Brown, Gary R Matzke
American Journal of Pharmaceutical Education|May 12, 2016
A Novel Education and Training Program to Enhance Student AdvocacyAlex J Adams, Gary R Matzke, Kenneth L McCall
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2003
Hepatic drug metabolism and transport in patients with kidney diseaseThomas D Nolin, Reginald F Frye, Gary R Matzke
Pharmacotherapy|April 29, 2009
Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysisBrett H Heintz, Gary R Matzke, William E Dager
Antimicrobial Agents and Chemotherapy|January 5, 2011
Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenemIolanda Cirillo, Nicole Vaccaro, Dainius Balis, et al.
Journal of Clinical Pharmacology|August 5, 2015
Influence of kidney disease on drug disposition: An assessment of industry studies submitted to the FDA for new chemical entities 1999-2010Gary R Matzke, Thomas C Dowling, Samantha A Marks, et al.
Pageof 4